title: Successful induction of molecular remission with single-agent anti-CD33 antibody (gemtuzumab ozogamicin) in chemotherapy-refractory relapse of acute myeloid leukaemia post-BMT.
authors.forename: R
authors.initials: R
authors.lastname: Swords
authors.forename: P J
authors.initials: PJ
authors.lastname: Hayden
authors.forename: K
authors.initials: K
authors.lastname: Molloy
authors.forename: M
authors.initials: M
authors.lastname: Lawlor
authors.forename: P V
authors.initials: PV
authors.lastname: Browne
authors.forename: P T
authors.initials: PT
authors.lastname: Murphy
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D000617:Aminoglycosides / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D015703:Antigens, CD / Q000276:immunology; D015214:Antigens, Differentiation, Myelomonocytic / Q000276:immunology; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D019008:Drug Resistance, Neoplasm; D000079982:Gemtuzumab; D006801:Humans; D007116:Immunization, Passive; D018796:Immunoconjugates / Q000627:therapeutic use; D007951:Leukemia, Myeloid / Q000188:drug therapy / Q000628:therapy*; D008297:Male; D012074:Remission Induction; D016879:Salvage Therapy; D063268:Sialic Acid Binding Ig-like Lectin 3; D014184:Transplantation, Homologous
chemical_list: D000617:Aminoglycosides; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D015703:Antigens, CD; D015214:Antigens, Differentiation, Myelomonocytic; C571163:CD33 protein, human; D018796:Immunoconjugates; D063268:Sialic Acid Binding Ig-like Lectin 3; D000079982:Gemtuzumab